Debt - Additional Information (Details)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
Jun. 18, 2022
$ / shares
shares
|
Jun. 17, 2022
$ / shares
shares
|
May 24, 2022 |
Apr. 30, 2022
USD ($)
$ / shares
shares
|
Nov. 03, 2021 |
Nov. 02, 2021 |
Sep. 30, 2021
USD ($)
|
Aug. 31, 2021
USD ($)
shares
|
Jan. 25, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Sep. 04, 2020
USD ($)
|
Jul. 02, 2020
USD ($)
|
Apr. 20, 2020
USD ($)
|
Aug. 12, 2019
USD ($)
$ / shares
shares
|
Jun. 30, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
|
Apr. 30, 2020
USD ($)
$ / shares
|
Apr. 30, 2022
USD ($)
$ / shares
shares
|
Feb. 17, 2023
$ / shares
|
Jan. 31, 2023
USD ($)
$ / shares
shares
|
Oct. 31, 2022 |
Sep. 08, 2022
$ / shares
shares
|
Nov. 30, 2021
$ / shares
shares
|
Oct. 31, 2021 |
Jul. 31, 2021
$ / shares
shares
|
Jun. 30, 2021
$ / shares
shares
|
Apr. 30, 2021
USD ($)
$ / shares
shares
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding term |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
5 years
|
| Number of times for loans to qualifying businesses average monthly payroll costs |
|
|
|
|
|
|
|
|
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock | shares |
61,913
|
77,443
|
|
77,443
|
|
|
|
|
|
|
|
|
|
|
77,443
|
|
|
|
77,443
|
|
139,356
|
|
1,683,470
|
|
|
|
|
|
| Warrants exercise price | $ / shares |
$ 0.0001
|
|
|
$ 0.0033
|
|
|
|
|
|
|
|
|
|
|
$ 0.0033
|
$ 0.0001
|
|
|
$ 0.0033
|
|
$ 0.0001
|
|
|
|
|
|
|
|
| Bridge Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock | shares |
|
1,365,960
|
|
1,365,960
|
|
|
|
|
|
|
|
|
|
|
1,365,960
|
|
|
|
1,365,960
|
|
|
|
1,683,470
|
19,697
|
|
11,084
|
11,084
|
13,992
|
| Warrants exercise price | $ / shares |
|
$ 5.16
|
|
$ 5.16
|
|
|
|
|
|
|
|
|
|
|
$ 5.16
|
|
|
|
$ 5.16
|
$ 4.25
|
|
|
$ 4.25
|
$ 6.05
|
|
$ 8.25
|
$ 8.25
|
$ 8.25
|
| Warrants outstanding term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series C Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding | shares |
|
|
|
463,265
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
463,265
|
|
403,228
|
|
|
|
|
|
|
463,265
|
| '$130K Note | FRV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt repayment notice period |
|
|
|
|
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| '$130K Note | Series C Preferred Stock | FRV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| $1M Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from notes payable |
|
|
|
|
|
|
|
|
|
|
$ 350,000
|
$ 350,000
|
|
|
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
| Maturity date |
|
|
Sep. 30, 2023
|
|
Sep. 30, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep. 30, 2021
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest rate per annum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.00%
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest |
|
|
|
$ 229,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 229,000
|
|
$ 204,000
|
|
|
|
|
|
|
$ 98,000
|
| Default interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00%
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,152
|
|
|
|
|
| Warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.89
|
|
|
|
|
| $1M Notes | John Q. Adams |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 126,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest |
|
|
|
$ 115,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 115,000
|
|
|
|
|
|
|
|
|
|
| $1M Notes | FRV | John Q. Adams |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
| $1.5M Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
$ 1,500,000
|
|
|
|
|
|
|
$ 1,500,000
|
|
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
| Proceeds from notes payable |
|
|
|
|
|
|
|
|
|
$ 1,490,000
|
|
|
|
|
|
|
$ 1,490,000
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity date |
|
|
|
|
|
Oct. 31, 2022
|
|
|
|
Jul. 31, 2022
|
|
|
|
|
|
|
Jul. 31, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 34,000
|
| Warrants issued to purchase common stock | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,545
|
|
|
|
|
| Warrants exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.89
|
|
|
|
|
| $1.5M Notes | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issues upon conversion of notes | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
909,071
|
|
|
|
909,071
|
|
|
|
|
|
|
|
|
|
| Conversion price | $ / shares |
|
|
|
$ 1.65
|
|
|
|
|
|
|
|
|
|
|
$ 1.65
|
|
|
|
$ 1.65
|
|
|
|
|
|
|
|
|
|
| $1.5M Notes | Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from notes payable |
|
|
|
|
|
|
|
|
|
$ 30,000
|
|
|
|
|
|
|
$ 30,000
|
|
|
|
|
|
|
|
|
|
|
|
| Bridge Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,695,555
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 22, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest rate per annum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 165,516
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Original issue discount rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amortization of Debt Discount (Premium) |
|
|
|
$ 469,555
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| deferred financing costs |
|
|
|
$ 555,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 555,767
|
|
|
|
|
|
|
|
|
|
| Bridge Notes | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issues upon conversion of notes | shares |
|
1,606,027
|
|
|
|
|
|
|
|
|
|
|
|
|
1,683,470
|
1,606,027
|
|
|
1,606,026
|
|
|
|
|
|
|
|
|
|
| Conversion price | $ / shares |
|
|
|
$ 2.89
|
|
|
|
|
|
|
|
|
|
|
$ 2.89
|
|
|
|
$ 2.89
|
|
|
|
|
|
|
|
|
|
| Shares cancelled upon conversion of notes | shares |
61,913
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bridge Notes | Bridge Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercise percentage of principal amount of notes purchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150.00%
|
|
|
150.00%
|
|
|
|
| Amortization of Debt Discount (Premium) |
|
|
|
$ 118,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paycheck Protection Program |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from loan |
|
|
|
|
|
|
|
|
$ 250,200
|
|
|
|
$ 250,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of times for loans to qualifying businesses average monthly payroll costs |
|
|
|
|
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unsecured Promissory Draw Down Note |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from notes payable |
|
|
|
|
|
|
$ 250,000
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest rate per annum |
|
|
|
|
|
|
|
12.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issues upon conversion of notes | shares |
|
|
|
|
|
|
|
10,101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Maturity Date, Description |
|
|
|
|
|
|
|
The note originally matured on October 11, 2021 and was amended on October 11, 2021 and again on November 29, 2021, extending maturity to November 30, 2021 and December 31, 2021, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercise price | $ / shares |
|
|
|
$ 15.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 49.5
|
15.18
|
|
$ 15.18
|
|
|
|
|
|
|
$ 49.5
|
| Maximum | '$130K Note | FRV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 130,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum | Unsecured Promissory Draw Down Note | Matthews Holdings Southwest, Inc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercise price | $ / shares |
|
|
|
$ 3.47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.47
|
$ 3.47
|
|
$ 0.0001
|
|
|
|
|
|
|
$ 3.47
|
| Minimum | Series C Preferred Stock | FRV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
71,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum | '$130K Note | Series C Preferred Stock | FRV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
71,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|